1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. BIOCON LTD.
Biocon Ltd. NSE: BIOCON | BSE: 532523
Mid-range Performer
Download real time
400.60 2.05 (0.51%)
37.66% Gain from 52W Low
1.6M
NSE+BSE Volume

NSE 22 Dec, 2025 12:40 PM (IST)

Watchlist

Portfolio

Alert
US FDA Classification
Biocon's New Jersey facility gets US FDA's voluntary action indicated (VAI) classification See details

Biocon quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents